Description

MONTRELIEF FX TAB is an advanced anti-allergic formulation containing Montelukast 10 mg, a leukotriene receptor antagonist (LTRA), and Fexofenadine 120 mg, a second-generation, non-sedating antihistamine. This combination offers effective relief from both upper respiratory tract allergies and skin-related allergic responses.

Montelukast blocks leukotrienes, which are inflammatory mediators involved in allergic reactions and asthma, reducing inflammation, bronchoconstriction, and mucus secretion.

Fexofenadine is an H1-receptor antagonist that prevents the action of histamine, providing fast and sustained relief from itching, sneezing, runny nose, and hives—without causing drowsiness.

This dual-action tablet is used for managing:

• Seasonal allergic rhinitis (hay fever)

• Perennial allergic rhinitis

• Chronic idiopathic urticaria (hives)

• Asthma-related inflammation

• Skin allergies and itching

Manufactured under WHO-GMP and ISO-certified facilities, MONTRELIEF FX TAB is globally exported by BLUEPILL EXPRESS, a reliable name in international pharmaceutical trade. The product is distributed across regulated and semi-regulated markets in Asia, Africa, Latin America, the Middle East, and Europe, with complete export documentation, labeling customization, and regulatory support.